PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report on the development of modern cancer therapies
Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/07/14 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report on the development of modern cancer therapies.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The new report, “Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments” forecasts that there is likely to be a dramatic change over the next five years in treatment methods.

While traditional cancer therapies like chemotherapy and radiation currently account for the most common forms of medical care today, newer immunological and biotherapy treatments will soon take up a larger share of the market, reaching 46% or $42 billion in sales by 2011.

There have been several successful new treatments products launched in the past, including Rituxan, Herceptin, Gleevec and Avastin. Their success has set the stage for belief that newer products will thrive just as well from a business standpoint. There are nearly 80 cancer immunotherapy products in late stage development for various cancer treatments, and therapeutics like Gardisil and Dacogen which have been recently approved, are likely to contribute to a further upsurge in the market.

The immunotherapy/biotherapy cancer market has benefited from several highly successful products, but it also has room for growth. The industry was estimated at $14.6 billion dollars in 2006, which represented a 36.4 % increase from 2004 estimates. The report forecasts that the potential world market is expected to exceed $60 billion within the next ten years.

Newer therapies are gaining widespread acceptance across the world. They are particularly used to treat lymphoma and breast cancer, and have generated the most revenues from treatment in these two segments. Cervical, lung and multiple myelomas have only lately been benefiting from recent immunological therapies, and are expected to be at the forefront of treatment from immunological and biotherapies.

The study examines the global market for monoclonal antibodies, vaccines, interleukins and interferons, antisense oligonucleotides, and apoptosis or programmed cell death as well as other therapies used as cancer treatments.
The report also delineates the market shares for companies in the field, profiles key companies and their current products, has global data from across the world and forecasts to 2011 for sales of monoclonal antibodies,vaccines and other biotherapeutic treatments.

“Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments,” is available from Report Buyer. For more information, please visit the website.

Report Buyer product ID: KAL00018

About Report Buyer
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 28,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Urmila Doraswami 
+44 207 060 7474 press[.]reportbuyer.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Report Buyer Ltd / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Inferior Vena Cava Filters Market to Register a Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)